Fisher & Paykel Healthcare's Limited Recall Announcement

Fisher & Paykel Healthcare Corporation Limited (ASX: $FPH) has initiated a voluntary limited recall of batches of Airvo 2 and myAirvo 2 devices manufactured before 14 August 2017. The recall is due to a speaker configuration issue that may result in distorted, intermittent, or inaudible alarm sound levels. The affected devices are used to deliver high flow therapy to patients, and the company estimates approximately 9,000 of these devices are still in use.

Executive Commentary on the Limited Recall

The company is taking proactive measures to address the speaker configuration issue in the affected devices. We are committed to ensuring the safety and well-being of patients using our products. Fisher & Paykel Healthcare is working closely with regulatory authorities and will replace any affected devices. We encourage customers with questions or concerns to reach out to our representatives for further information.

Summary of Fisher & Paykel Healthcare's Announcement

Fisher & Paykel Healthcare Corporation Limited (ASX: $FPH) has initiated a voluntary limited recall of Airvo 2 and myAirvo 2 devices due to a speaker configuration issue affecting alarm sound levels. The company estimates approximately 9,000 affected devices are still in use and will be replacing them. Additionally, the company anticipates costs of approximately $12 million associated with this recall, which will be provisioned for in the financial statements for the year ended 31 March 2024. Furthermore, the company advises on changes to building depreciation deductions in New Zealand, which may impact its tax expense for the 2024 financial year. Fisher & Paykel Healthcare remains committed to its mission of providing high-quality products for respiratory care, surgery, and sleep apnea treatment.